Approved Technologies

The SAFETY Act provides two levels of liability protections for approval: Designation and Certification. By obtaining either Designation or Certification, companies obtain a level of legal protection in case their technology is ever put to use during a terrorist attack. See below for a list of approved technology certifications.





Company/Technology

Human Genome Sciences, Inc.: ABthrax

Approved: August 14, 2007 | Expires: September 30, 2012

Human Genome Sciences, Inc. provides ABthrax, a human monoclonal antibody drug against the protective antigen component of anthrax toxin, for use as part of the Strategic National Stockpile. The Technology acts as a prophylactic and therapeutic product by preventing anthrax-related toxin from infiltrating and destroying human cells.